FHB:NASDAQFirst Hawaiian, Inc. Analysis
Data as of 2026-09-26 - not real-time
$25.25
Latest Price
3/10Risk
Risk Level: Low
Executive Summary
First Hawaiian, Inc. is priced at $25.25, and its moving averages give no clean directional read — the structure is neutral. The last 30 days have lost 9.4%. Relative strength is 38.5 — approaching oversold — and the MACD signal is bullish. Watch $24.67 as support and $26.18 as the nearer resistance level.
The shares look undervalued, trading on 11.0 times earnings below a sector average of 15.6. Sell-side targets cluster 20.6% above the current quote. Revenue is growing at 5.9% on a 32.3% profit margin. The 4.12% dividend yield looks covered by current payout levels.
Risk scores 3 out of 10, which is low for this asset class. With 30-day volatility of 14.5%, a beta of 0.68 and a maximum drawdown of 18.3%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons diverge: hold near-term but buy on a long view, at 6/10 conviction over the longer horizon.
The shares look undervalued, trading on 11.0 times earnings below a sector average of 15.6. Sell-side targets cluster 20.6% above the current quote. Revenue is growing at 5.9% on a 32.3% profit margin. The 4.12% dividend yield looks covered by current payout levels.
Risk scores 3 out of 10, which is low for this asset class. With 30-day volatility of 14.5%, a beta of 0.68 and a maximum drawdown of 18.3%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons diverge: hold near-term but buy on a long view, at 6/10 conviction over the longer horizon.
Top Market Events
The end of the earnings season is always a good time to take a step back and see who shined and who didn’t .Detailed price information for First Hawaiian Inc FHB-Q from The Globe and Mail including charting and trades.Detailed price information for First Hawaiian Inc FHB-Q from The Globe and Mail including charting and trades.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 4/10
Key Factors
- Trading below the 200-day average of 26.69
- MACD momentum is positive
- 30-day price change of -9.4%
Medium Term
1–3 yearsPositive
Model confidence: 5/10
Key Factors
- P/E of 11.0 versus sector average of 15.6
- Trading below the 200-day average of 26.69
- Analyst targets imply +20.6% versus the current price
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- P/E of 11.0 versus sector average of 15.6
- Analyst targets imply +20.6% versus the current price
- Profit margin of 32.3% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth5.90%
Profit Margin32.34%
P/E Ratio11.0
ROE10.32%
ROA1.20%
P/B Ratio1.1
Op. Cash Flow$334.9M
Industry P/E15.6
Technical Analysis
TrendNeutral
RSI38.5
Support$24.67
Resistance$26.18
MA 20$25.60
MA 50$26.79
MA 200$26.69
MACDBullish
VolumeIncreasing
Fear & Greed Index94.88
Valuation
Fair Value$38.03
Target Price$30.44
Upside/Downside20.57%
GradeUndervalued
TypeValue
Dividend Yield4.12%
Risk Assessment
Beta0.68
Volatility14.46%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.